SB 290157

CAS No. 259218-28-5

SB 290157( SB-290157 | SB290157 )

Catalog No. M13784 CAS No. 259218-28-5

A potent, selective nonpeptide antagonist of anaphylatoxin C3a receptor (C3aR) with IC50 of 200 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SB 290157
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective nonpeptide antagonist of anaphylatoxin C3a receptor (C3aR) with IC50 of 200 nM.
  • Description
    A potent, selective nonpeptide antagonist of anaphylatoxin C3a receptor (C3aR) with IC50 of 200 nM; does not antagonize the C5aR or 5 other chemotactic GPCRs on human neutrophils; blocks C3a-induced C3aR internalization and C3a-induced Ca(2+) mobilization in RBL-C3aR cells and human neutrophils with IC50 of 27.7 and 28 nM, respectively; also inhibits C3a-induced Ca2+ mobilization of mouse and guinea pig C3aRS with IC50 of 7 and 12.5 nM, respectively; potently inhibits C3a-mediated ATP release from guinea pig platelets and inhibits C3a-induced potentiation of the contractile response to field stimulation of perfused rat caudal artery, demonstrates antiinflammatory activity in animal models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SB-290157 | SB290157
  • Pathway
    Immunology/Inflammation
  • Target
    Complement System
  • Recptor
    Complement System
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    259218-28-5
  • Formula Weight
    412.49
  • Molecular Formula
    C22H28N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    N(2)-[(2,2-diphenylethoxy)acetyl]-L-arginine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ames RS, et al. J Immunol. 2001 May 15;166(10):6341-8. 2. Therien AG. J Immunol. 2005 Jun 15;174(12):7479; author reply 7479-80. 3. Ratajczak J, et al. Blood. 2004 Mar 15;103(6):2071-8. 4. Proctor LM, et al. Br J Pharmacol. 2004 Jun;142(4):756-64.
molnova catalog
related products
  • BR103

    BR103 is a potent, metabolically stable and highly selective small molecule agonist of complement C3a receptor (C3aR) with EC50 of 22?±?8 ?nM.

  • W-54011

    A potent and orally active non-peptide C5a receptor (CD88;C5aR) antagonist with Ki of 2.2 nM.

  • BR111

    BR111 is a potent, highly selective and orally active antagonist of complement C3a receptor (C3aR) with IC50 of 85?±?40 ?nM.